Identification and functional analysis of genetic variants of the human β-glucuronidase in a German population sample

Pharmacogenetics and Genomics

Volumn 15, Issue 12, 2005, Pages 875-881

  Gratz, Matthias ^a   Kunert Keil, Christiane ^a,b   John, Ulrich ^c   Cascorbi, Ingolf ^a,d   Kroemer, Heyo K ^a,c  

^a Institute of Pharmacology   (Germany)

^b Rheinisch Westfalische TH Aachen   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Reporter gene assay; Single nucleotide polymorphism (SNP); Study of health in pomerania (SHiP); glucuronidase

Indexed keywords

BETA GLUCURONIDASE;

ADULT; AGED; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FUNCTIONAL ASSESSMENT; GENDER; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GERMANY; HEREDITY; HUMAN; MALE; MUCOPOLYSACCHARIDOSIS TYPE 7; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 27944465716     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01213011-200512000-00005     Document Type: Article

References (25)

1. Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr 1973; 82:249-257.
2. Speleman F, Vervoort R, van Roy N, Liebaers I, Sly WS, Lissens W. Localization by fluorescence in situ hybridization of the human functional beta-glucuronidase gene (GUSB) to 7q11.21- > q11.22 and two pseudogenes to 5p13 and 5q13. Cytogenet Cell Genet 1996; 72:53-55.
3. Tomatsu S, Fukuda S, Sukegawa K, Ikedo Y, Yamada S, Yamada Y, et al. Mucopolysaccharidosis type VII: characterization of mutations and molecular heterogeneity. Am J Hum Genet 1991; 48:89-96.
4. Vervoort R, Gitzelmann R, Bosshard N, Maire I, Liebaers I, Lissens W. Low beta-glucuronidase enzyme activity and mutations in the human beta-glucuronidase gene in mild mucopolysaccharidosis type VII, pseudodeficiency and a heterozygote. Hum Genet 1998; 102:69-78.
5. Chabas A, Giros ML, Guardiola A. Low beta-glucuronidase activity in a healthy member of a family with mucopolysaccharidosis VII. J Inherit Metab Dis 1991; 14:908-914.
6. Bosslet K, Straub R, Blumrich M, Czech J, Gerken M, Sperker B, et al. Elucidation of the mechanism enabling tumor selective prodrug monotherapy. Cancer Res 1998; 58:1195-1201.
7. Murdter TE, Sperker B, Kivisto KT, McClellan M, Fritz P, Friedel G, et al. Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. Cancer Res 1997; 57:2440-2445.
8. Murdter TE, Friedel G, Backman JT, McClellan M, Schick M, Gerken M, et al. Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase. J Pharmacol Exp Ther 2002; 301:223-228.
9. Sperker B, Murdter TE, Schick M, Eckhardt K, Bosslet K, Kroemer HK. Interindividual variability in expression and activity of human beta-glucuronidase in liver and kidney: consequences for drug metabolism. J Pharmacol Exp Ther 1997; 281:914-920.
10. Sperker B, Tomkiewicz C, Burk O, Barouki R, Kroemer HK. Regulation of human beta-glucuronidase by A23187 and thapsigargin in the hepatoma cell line HepG2. Mol Pharmacol 2001; 59:177-182.
11. Lotsch J, Sperker B, Kroemer HK, Geisslinger G. Verapamil decreases glucuronidase activity in the gut. Biochem Pharmacol 2002; 63:1575-1578.
12. Grube M, Kunert-Keil C, Sperker B, Kroemer HK. Verapamil regulates activity and mRNA-expression of human beta-glucuronidase in HepG2 cells. Naunyn Schmiedeberg's Arch Pharmacol 2003; 368:463-469.
13. Kunert-Keil C, Sperker B, Bien S, Wolf G, Grube M, Kroemer HK. Involvement of AP-2 binding sites in regulation of human beta-glucuronidase. Naunyn Schmiedeberg's Arch Pharmacol 2004; 370:331-339.
14. John U, Greiner B, Hensel E, Ludemann J, Piek M, Sauer S, et al. Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 2001; 46:186-194.
15. Jain S, Drendel WB, Chen ZW, Mathews FS, Sly WS, Grubb JH. Structure of human beta-glucuronidase reveals candidate lysosomal targeting and active-site motifs. Nat Struct Biol 1996; 3:375-381.
16. Calvo P, Barba JL, Cabezas JA. Serum beta-N-acetylglucosaminidase, beta-D-glucosidase, alpha-D-glucosidase, beta-D-fucosidase, alpha-L-fucosidase and beta-D-galactosidase levels in acute viral hepatitis, pancreatitis, myocardial infarction and breast cancer. Clin Chim Acta 1982; 119:15-19.
17. Lombardo A, Bairati C, Goi G, Roggi C, Maccarini L, Bollini D, et al. Plasma lysosomal glycohydrolases in a general population. Clin Chim Acta 1996; 247:39-49.
18. Owerbach D, Luis AJ. Phenobarbital induction of egasyn: availability of egasyn in vivo determines glucuronidase binding to membrane. Biochem Biophys Res Commun 1976; 69:628-634.
19. Brot FE, Bell CE Jr, Sly WS. Purification and properties of beta-glucuronidase from human placenta. Biochemistry 1978; 17:385-391.
20. Shipley JM, Miller RD, Wu BM, Grubb JH, Christensen SG, Kyle JW, et al. Analysis of the 5′ flanking region of the human beta-glucuronidase gene. Genomics 1991; 10:1009-1018.
21. Islam MR, Tomatsu S, Shah GN, Grubb JH, Jain S, Sly WS. Active site residues of human beta-glucuronidase. Evidence for Glu(540) as the nucleophile and Glu(451) as the acid-base residue. J Biol Chem 1999; 274:23451-23455.
22. Lombardo A, Caimi L, Marchesini S, Goi GC, Tettamanti G. Enzymes of lysosomal origin in human plasma and serum: assay conditions and parameters influencing the assay. Clin Chim Acta 1980; 108:337-346.
23. Cobben NA, Drent M, De Vries J, Wouters EF, Dieijen-Visser MP, Henderson RF. Serum beta-glucuronidase activity in a population of ex-coalminers. Clin Biochem 1999; 32:659-664.
24. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science 2001; 291:1304-1351.
25. Marsh S, Xiao M, Yu J, Ahluwalia R, Minton M, Freimuth RR, et al. Pharmacogenomic assessment of carboxylesterases 1 and 2. Genomics 2004; 84:661-668.